Affordable Access

Publisher Website

Consensus guidelines for the design and implementation of clinical trials in ALS

Authors
Journal
Journal of the Neurological Sciences
0022-510X
Publisher
Elsevier
Publication Date
Volume
169
Identifiers
DOI: 10.1016/s0022-510x(99)00209-9
Keywords
  • Als
  • Motor Neuron Disease
  • Clinical Trials
  • Guidelines
  • Therapeutic Trials
  • Theodore H. Munsat
  • Conference Organizer
  • Chairman Wfn Research Committees
Disciplines
  • Medicine
  • Pharmacology

Abstract

Abstract Background: In 1994 consensus guidelines were developed for conducting clinical trials in ALS. With growing experience in clinical trials, it has become clear that a number of further guidelines were needed. Methods: Under the auspices of the World Federation of Neurology Committee on Research, a multinational group of neurologists, statisticians, patient advocates, representatives from the pharmaceutical industry as well as regulatory agencies developed consensus about a number of revisions to the existing guidelines during a 2 day conference in April 1998. Results: Expanded areas of focus include greater protection of patient rights, more detailed guidelines for outcome measures statistical analyses, disclosure of study results and improved interaction between investigators and the corporate sector. Comment: Substantial progress has been made in standardizing and improving the quality of clinical trials in ALS through these consensus guidelines.

There are no comments yet on this publication. Be the first to share your thoughts.

Statistics

Seen <100 times
0 Comments